Goenomics — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Goenomics is a precision genome annotation service provider that has developed a proprietary technology platform, 'mendle', designed to dramatically reduce false positives and deliver highly reliable genomic data. The company targets a diverse customer base including industrial leaders in plant/animal breeding and academic research institutions, offering both standardized services and customized solutions. Founded in 2020 by Dr. Martin Kollmar and Dr. Dominic Simm, the company is privately held and appears to be in an early-revenue stage, building its market presence through strategic partnerships like the one announced with Dovetail Genomics. Its value proposition centers on saving researchers time and cost by providing foundational, high-quality annotation data that underpins downstream experimental and breeding programs.

Genetics & Genomics

Technology Platform

Proprietary 'mendle' technology for high-precision genome annotation, focusing on reducing false positives. Includes a unified search platform aggregating global genome assembly data.

Opportunities

The rapid expansion of genomic sequencing in agriculture, biotechnology, and conservation creates a growing need for accurate, outsourced annotation services.

Strategic partnerships with sequencing companies can provide a steady pipeline of customer assemblies.

The development of its unified genome search platform could evolve into a widely-used database, creating network effects and a scalable SaaS revenue stream.

Risk Factors

Intense competition from both free, open-source annotation pipelines and established commercial bioinformatics software vendors.

Dependency on the research budgets of academic and industrial clients, which can be volatile.

The challenge of scaling a service-based business reliant on deep expertise while maintaining quality and profitability.

Competitive Landscape

Goenomics competes with open-source annotation pipelines (e.g., NCBI's PGAAP, Ensembl's pipeline, BRAKER) that require in-house expertise, and with commercial bioinformatics software and service providers like Geneious, DNASTAR, and Eurofins Genomics. Its differentiation hinges on the claimed superior accuracy of its proprietary 'mendle' technology and its integrated search platform, targeting customers who prioritize data quality over lowest cost.

More companies in Diagnostics & Precision Medicine →More companies in Germany →